Persicaria Hydropiper (L.) Spach and Its Flavonoid Components, Isoquercitrin and Isorhamnetin, Activate the Wnt/β-catenin Pathway and Inhibit Adipocyte Differentiation of 3T3-L1 Cells
Overview
Authors
Affiliations
Obesity, which is related to metabolic syndrome and is associated with liver disease, represents an epidemic problem demanding effective therapeutic strategies. Evidence shows that the Wnt/β-catenin pathway is closely associated with obesity and that small molecules regulating the Wnt/β-catenin pathway can potentially control adipogenesis related to obesity. Eleven plant extracts activating the Wnt/β-catenin pathway were screened by using HEK 293-TOP cells retaining the Wnt/β-catenin signaling reporter gene. An extract of Persicaria hydropiper (L.) Spach was found to activate Wnt/β-catenin signaling. P. hydropiper is grown worldwide in temperate climates and is found widely in Southeast Asia. The P. hydropiper extract inhibited the differentiation of adipocyte 3T3-L1 cells. Isoquercitrin and isorhamnetin, constituents of P. hydropiper, also activated Wnt/β-catenin signaling and suppressed the differentiation of 3T3-L1 cells. These results indicate that isoquercitrin in P. hydropiper suppresses the adipogenesis of 3T3-L1 cells via the inhibition of Wnt/β-catenin signaling. P. hydropiper and isoquercitrin may therefore be potential therapeutic agents for obesity and its associated disorders.
Phytochemical Composition of (L.) Lam and Its Impact on the Metabolic Syndrome: A Review.
Alla C, Ali A, Mehiou A, Salhi Y, Bouanani N, Legssyer A Adv Pharmacol Pharm Sci. 2025; 2025:8276090.
PMID: 40035065 PMC: 11873318. DOI: 10.1155/adpp/8276090.
effects of phytochemicals on adipogenesis with a focus on molecular mechanisms: A systematic review.
Kazemi N, Ramazani E, Tayarani-Najaran Z Iran J Basic Med Sci. 2025; 28(4):409-425.
PMID: 39968092 PMC: 11831750. DOI: 10.22038/ijbms.2025.78924.17090.
Bioelectric medicine: unveiling the therapeutic potential of micro-current stimulation.
Lee H, Cho S, Kim D, Lee T, Kim H Biomed Eng Lett. 2024; 14(3):367-392.
PMID: 38645592 PMC: 11026362. DOI: 10.1007/s13534-024-00366-3.
Dayarathne L, Ko S, Yim M, Lee J, Kim J, Oh G Mar Drugs. 2024; 22(2).
PMID: 38393062 PMC: 10890497. DOI: 10.3390/md22020091.
Naomi R, Teoh S, Halim S, Embong H, Hasain Z, Bahari H Antioxidants (Basel). 2023; 12(8).
PMID: 37627544 PMC: 10451614. DOI: 10.3390/antiox12081549.